Genentech plans to invest more than $700 million in a new 700,000-ft 2 drug manufacturing facility in Holly Springs, NC. The project is expected to add more than 400 manufacturing jobs when the site ...

Genentech will more than double the initial investment in a state-of-the-art biomanufacturing facility in Holly Springs to approximately $2 billion, bolstering Roche and Genentech’s $50 billion ...

– The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D – – The facility will create more than 1,900 jobs and support the ...

(RTTNews) - Genentech announced plans to invest more than $700 million in a new 700,000 square foot state-of-the-art drug manufacturing facility in Holly Springs, NC. The project will add more than ...

A new biotechnology plant is set to boost North Carolina's economy by more than $3 billion. Medical manufacturing company Genentech plans to invest $700 million to build the new facility in Holly ...

Genentech increased its investment in a new Holly Springs, NC manufacturing facility. The company’s financial decision will more than double the initial total commitment for the company’s first East ...

Genentech, a South San Francisco, Calif.-based subsidiary of European biotech company Roche Group, plans to build a $700-million manufacturing facility in North Carolina. The 700,000-sq-ft high-volume ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The North Carolina town where ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced an expansion of its initial investment in a new Holly Springs, North ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million in a new 700,000 square foot ...